Technology
Health
Biotechnology

Minerva Neurosciences

765

$8.91
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.09 (-1.00%) As of 2:34 PM EST today
-$0.09 (-1.00%) Today

Why Robinhood?

You can buy or sell NERV and other stocks, options, ETFs, and crypto commission-free!

About NERV

Minerva Neurosciences, Inc Common Stock, also called Minerva Neurosciences, is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. Its product pipeline includes Roluperidone, Seltorexant, MIN-117, and MIN-301. Read More The company was founded by Rogerio Vivaldi Coelho on April 23, 2007 and is headquartered in Cambridge, MA.

CEO
Rémy Luthringer
Employees
13
Headquarters
Waltham, Massachusetts
Founded
2007
Market Cap
340.30M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
282.44K
High Today
$9.14
Low Today
$8.83
Open Price
$9.00
Volume
136.80K
52 Week High
$9.56
52 Week Low
$4.01

Collections

Technology
Health
Biotechnology
Medical
Biopharmaceutical
Pharmaceutical
2014 IPO
US

NERV Earnings

-$0.42
-$0.28
-$0.14
-$0.00
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
— per share
Actual
Expected Mar 10, Pre-Market

People Also Bought

Viking Therapeutics

38,964

$6.88

-1.22%

Viking Therapeutics

38,964

$6.88

-1.22%

Catalyst Pharmaceuticals

52,477

$5.20

-0.10%

Hexo

166,615

$1.41

-2.08%

Corbus Pharmaceuticals

49,073

$5.57

-1.76%

Plug Power

211,401

$5.46

-0.91%

NIO

127,918

$4.04

-5.28%

CannTrust

103,242

$0.8152

-3.02%

Vivint Solar

70,994

$11.40

-11.28%

Aphria

99,573

$4.15

-2.62%

Verastem

17,519

$2.17

+3.49%

Sorrento Therapeutics

12,107

$2.53

-4.53%

Aurora Cannabis

671,428

$1.65

-1.49%

You May Also Like

CLAR
COLM
CPAAW
DRIP
DQ
ALG
OMAB
ACLS
CVM
GRN
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy NERV

Market Price$8.91
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell NERV stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up